scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1049702888 |
P356 | DOI | 10.1038/SJ.BJC.6603434 |
P8608 | Fatcat ID | release_nd2murqkdrhsvly6hwt3is6osu |
P932 | PMC publication ID | 2360594 |
P698 | PubMed publication ID | 17060935 |
P5875 | ResearchGate publication ID | 6735017 |
P2093 | author name string | P Kvasnicka | |
J Bodo | |||
J Jakubikova | |||
J Duraj | |||
J Kasparkova | |||
J Sedlak | |||
L Hunakova | |||
P2860 | cites work | Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death | Q28570235 |
Cisplatin: mode of cytotoxic action and molecular basis of resistance | Q29615385 | ||
Cellular processing of platinum anticancer drugs | Q29617899 | ||
Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours | Q33369069 | ||
Role of Gadd45 in apoptosis | Q33800735 | ||
Regulation of the G2/M transition by p53. | Q33943437 | ||
Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase/mitogen-activated protein kinase signal transduction pathway: potential role in promoting cytotoxic drug action | Q34222916 | ||
p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress | Q34325063 | ||
Cisplatin: from DNA damage to cancer chemotherapy. | Q34348474 | ||
Design of new anticancer therapies targeting cell cycle checkpoint pathways | Q34416851 | ||
Apoptotic effect of ethyl-4-isothiocyanatobutanoate is associated with DNA damage, proteasomal activity and induction of p53 and p21cip1/waf1. | Q34546094 | ||
Mitogen-activated protein kinases in apoptosis regulation | Q35743118 | ||
Molecular mechanisms of platinum resistance: still searching for the Achilles' heel | Q35943355 | ||
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial. | Q36613503 | ||
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells | Q36616527 | ||
Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines | Q36648770 | ||
Vegetables, fruit, and cancer. I. Epidemiology | Q37110546 | ||
p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells | Q37385633 | ||
Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress | Q39528509 | ||
Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations | Q40255489 | ||
Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho. | Q40268151 | ||
Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate. | Q40351970 | ||
Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. | Q40385121 | ||
Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines | Q40575641 | ||
The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis. | Q40598314 | ||
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells | Q40664009 | ||
XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells | Q40816011 | ||
Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin | Q40859019 | ||
Chemoprevention by isothiocyanates | Q40933059 | ||
Cisplatin induces a persistent activation of JNK that is related to cell death | Q41062943 | ||
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. | Q41120735 | ||
Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines | Q41514546 | ||
Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL. | Q42278494 | ||
Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry | Q43554593 | ||
Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology | Q43609590 | ||
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation | Q43983996 | ||
Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis | Q44701264 | ||
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy. | Q46835743 | ||
Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. | Q54111946 | ||
Dose-related inhibition by dietary phenethyl isothiocyanate of esophageal tumorigenesis and DNA methylation induced by N-nitrosomethylbenzylamine in rats | Q70487344 | ||
Monochlorobimane fluorometric method to measure tissue glutathione | Q73093514 | ||
Mechanism of nitric oxide-induced apoptosis in human neuroblastoma SH-SY5Y cells | Q73191402 | ||
Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells | Q73574350 | ||
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin | Q77663596 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1348-1353 | |
P577 | publication date | 2006-10-24 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations | |
P478 | volume | 95 |
Q36265840 | Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells |
Q35143496 | Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma |
Q47434492 | Baker's Yeast Sensitizes Metastatic Breast Cancer Cells to Paclitaxel In Vitro |
Q39462960 | Cytotoxic properties of Adamantyl isothiocyanate and potential in vivo metabolite adamantyl-N-acetylcystein in gynecological cancer cells |
Q39496590 | Description of the cytotoxic effect of a novel drug Abietyl-Isothiocyanate on endometrial cancer cell lines |
Q64111721 | Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells |
Q53550376 | Isothiocyanate E-4IB induces MAPK activation, delayed cell cycle transition and apoptosis. |
Q37010601 | Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells |
Q34214923 | Lipoplatin formulation review article |
Q90522692 | Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells |
Q34076604 | Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates |
Q33728766 | Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells |
Q36057163 | Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo. |
Search more.